Applied Cells Inc. and Immuneel Therapeutics Private Limited today announced that the companies have entered into a collaboration framework to jointly evaluate application of Applied Cells' MARS(R) ...
Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...
Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.
Researchers at the University of British Columbia developed a reliable method to produce helper T cells from stem cells by ...
The first GMP cell therapy product ever manufactured for clinical use on the Cell Shuttle™ and released using Cell Q™, is expected to be infused into patients within Cabaletta’s RESET™ clinical trial ...
On Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held ...
SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the ...
"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...
Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...
Hong Kong-based biomed pioneer is at the forefront in a global race to develop cell and gene treatments for cancers and other ...
Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.
Electric vehicles already deliver what most drivers say they want: a quiet, comfortable car that is cheap to run and does not spew exhaust. Yet even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback